Log In
BCIQ
Print this Print this
 

ARTISS

  Manage Alerts
Collapse Summary General Information
Company Baxter International Inc.
DescriptionSealant consisting of human fibrinogen and low concentration human thrombin
Molecular Target Fibrinogen ; Thrombin (Factor IIa) (F2)
Mechanism of ActionSealant
Therapeutic ModalityBiologic: Protein

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today